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Abstract:
The tissue integration of synthetic polymers can be promoted by displaying RGD peptides at
the biointerface with the objective of enhancing colonization of the material by endogenous
2cells. A firm but flexible attachment of the peptide to the polymer matrix, still allowing
interaction with receptors, is therefore of interest. Here, the covalent coupling of flexible
physical anchor groups, allowing for temporary immobilization on polymeric surfaces via
hydrophobic or dipole-dipole-interactions, to a RGD peptide was investigated. For this
purpose, a stearate or an oligo(ethylene glycol) (OEG) was attached to GRGDS in 51–70%
yield. The obtained RGD-linker constructs were characterized by NMR, IR and MALDI-ToF
mass spectrometry, revealing that the commercially available OEG and stearate linkers are in
fact mixtures of similar compounds. The RGD-linker constructs were co-electrospun with
poly(p-dioxanone) (PPDO). After electrospinning, nitrogen could be detected on the surface
of the PPDO fibers by X-ray photoelectron spectroscopy. The nitrogen content exceeded the
calculated value for the homogeneous material mixture suggesting a pronounced presentation
of the peptide on the fiber surface. Increasing amounts of RGD-linker constructs in the
electrospinning solution did not lead to a detection of an increased amount of peptide on the
scaffold surface, suggesting inhomogeneous distribution of the peptide on the PPDO fiber
surface. Human adipose-derived stem cells cultured on the patches showed similar viability as
when cultured on PPDO containing pristine RGD. The fully characterized RGD-linker
constructs could serve as valuable tools for the further development of tissue-integrating
polymeric scaffolds.
Introduction
Electrospinning of polymers has evolved into a versatile technology for the production of
micro- and nanofibrous scaffolds[1, 2] with porous morphologies closely resembling the
architecture of the extracellular matrix (ECM).[3] Such non-woven three-dimensional fiber
meshes can serve as a substrate for cell seeding.[4] The adhesion of cells on synthetic
polymers and their integration in tissues can be promoted by moieties, which can undergo
physical interaction with receptor proteins. A prominent example for such a ligand is adhesion
3sequences of amino acids such as the tripeptide RGD.[5] Aliphatic polyesters, which are
widely applied in temporary implants, lack functional groups allowing covalent coupling of
peptides. An interesting option to realize RGD presentation on a polymer fiber is its physical
incorporation by co-electrospinning.[6] Leaking of RGD as soluble RGD may, however,
inhibit cell adhesion and might promote apoptosis.[7]
Here, the attachment of physical anchor groups to RGD, which enhance the physical
interaction to the polymer matrix, and the potential of co-electrospun PPDO/RGD linker
construct scaffolds as substrates for cell seeding were explored. Two kinds of anchor groups
envisioned to promote the display of hydrophilic peptides on (hydrophobic) polymer matrices
in aqueous environments were selected: an oligo(ethylene glycol) (OEG7) derivative because
of its structural similarity to PPDO allowing hydrophic and dipole-dipole interactions and
stearate because of its pronounced hydrophobicity. The covalent coupling of such anchor
groups to the pentapeptide GRGDS as well as characterization of the synthesized RGD-linker
constructs with 1H and 13C NMR, ATR-FTIR and MALDI ToF mass spectrometry is
presented. In a subsequent step, these RGD-linker constructs were co-electrospun with PPDO
and the presence of the peptides on the surface was assessed by FT-IR and X-ray
photoelectron spectroscopy (XPS). Finally, in a preliminary biological evaluation co-
electrospun PPDO/OEG7-GRGDS was compared to PPDO/RGD as a substrate for the growth
of human adipose-derived mesenchymal stroma cells (hADSC).
Experimental
GRGDS (H-Gly-Arg-Gly-Asp-Ser-OH) was purchased from Bachem (Bubendorf, BL,
Switzerland), stearic acid N-hydroxysuccinimide ester was purchased from Sigma-Aldrich
(St. Louis, MO, USA) and MeO-OEG7-NHS was purchased from Broadpharm (San Diego,
CA, USA). Polydioxanone (PPDO; Resomer X206S, inherent viscosity of 1.5–2.2 dl/g [0.1%
in HFIP, 30 °C], residual monomer content: max. 0.5%) was acquired in the form of white
4granules (Evonik Industries AG, Essen, Germany), and 1,1,1,3,3,3-hexafluoro-2-propanol
(HFIP) was obtained from Sigma-Aldrich (Gillingham, UK). All other solvents were
purchased from commercial suppliers in analytical grade and were used as received.
NMR spectra were acquired on a DRX 500 Avance spectrometer (Bruker, Rheinstetten,
Germany). MALDI-ToF spectra were measured on an Ultraflextreme instrument (Bruker
Bremen, Germany). ESI-ToF spectra were measured on an Agilent 6210 ESI-TOF instrument
(Agilent Technologies, Santa Clara, CA, USA). ATR-FTIR spectra were recorded on Nicolet
6700 FT-IR (Thermo Fisher Scientific, Waltham, MA, USA) and Spectrum 100 FTIR (Perkin
Elmer, Waltham, MA, USA) spectrometers.
Synthesis of OEG7-GRGDS:
GRGDS (51.6 mg, 105 μmol) and MeO-OEG7-NHS (53.6 mg, 105 μmol) were dissolved in a 
mixture of DMSO and H2O (10:1, 2.8 ml) and were stirred at room temperature for 1 day. The
solvent was removed under reduced pressure and the remaining residue was filtered through
silica gel (200-400 mesh, 60 Å) with EtOAc/MeOH = 1:1 as eluent. After removal of the
solvent under reduced pressure, the obtained crude product was purified by reverse phase
HPLC [Varian Prostar HPLC system, Polymer Laboratories PLRP-S column (1212-6800,
300 × 25 mm, 100 Å pore size, 8 µm particle size), UV detector ( = 254 and 220 nm)] using
a gradient between solution A (90% H2O, 10% MeCN, 0.1%TFA) and solution B (90%
MeCN, 10% H2O, 0.1% TFA) at a flow rate of 8 ml/min. After lyophilization of the product
fractions, MeO-OEG7-GRGDS was obtained as a colorless oil (47 mg, 51%).
1H NMR (500 MHz, DMSO-d6): δ = 12.51 (bs, 2H, COOH), 8.26 (t, J = 5.7 Hz, 1 H,
NH(Gly)), 8.17 (d, J = 8.0 Hz, 1H, NH(Asp)), 8.09 (t, J = 5.7 Hz, 1H, NH(Gly)), 8.04 (d, J = 7.8
Hz, 1H, NH(Arg)), 7.90 (d, J = 7.9 Hz, 1H, NH(Ser)), 7.57 (t, J = 5.8 Hz, 1H, NH(Arg)), 7.37–6.98
(2 brs, 3H, NH(Arg)), 4.68–4.64 (m, 1H, CH(Asp)), 4.29 (m, 1H, CH(Arg)), 4.23 (m, 1H, CH(Ser)),
3.75–3.58, (3 m, 6H, CH2(Gly), CH2(Ser)), 3.50 (bs, 28H, OCH2), 3.44 (mc, 2H, CH3OCH2), 3.23
5(s, 3H, OCH3), 3.08 (m, 2H, CH2(Arg)), 2.69 (dd, J = 16.6, 5.2 Hz, 1H, CH2(Asp)), 2.49 (dd, J =
16.6, 5.2 Hz, 1H, CH2(Asp)), 2.39 (t, J = 6.3 Hz, 2H, OCH2CH2CONH), 1.70, 1.55–1.46 (3 m,
2H, 1H, 1H, CH2(Arg)) ppm. The Signal for OH(Ser) could not unambiguously be assigned. 13C
NMR (126 MHz, DMSO-d6): δ = 171.74, 171.70*, 170.65, 170.63, 169.1, 168.6, 169.2, 168.4 
(6 s, CO), 156.8 (s, NHCNH2), 71.3 (t, CH3OCH2), 69.8**, 69.7, 69.6, 66.5 (4 t, OCH2), 61.3
(t, CH2(Ser)), 58.1 (q, OCH3), 54.8 (d, CH(Ser)), 52.2 (d, CH(Arg)), 49.2 (d, CH(Asp)), 42.0, 41.9 (2
t, CH2(Gly)), 40.4 (t, CH2(Arg)), 36.3 (t, CH2(Asp)), 35.9 (t, OCH2CH2CONH), 29.1, 24.9, (2 t,
CH2(Arg)) ppm. *Signal with high intensity corresponds to two carbon atoms. **Signal with
very high intensity, corresponds to multiple carbon atoms of the OEG chain. IR (ATR): ν = 
3300–3200 (N―H, O―H), 3065, 2920–2875 (C―H), 1650, 1530 (C=O), 1195, 1120–1095, 
1025, 1005 cm-1. MS (MALDI): [M + H]+: C35H65N8O18+ calcd.: 885.44 m/z; found: 885.89
m/z, [M + Na]+ C35H64N8NaO18+ calcd.: 907.42 m/z; found: 907.80 m/z. MS (ESI-TOF): [M
+ H]+: C35H65N8O18+ calcd.:885.4411 m/z; found: 885.4421 m/z; [M + Na]+: C35H64N8NaO18+
calcd.: 907.4231 m/z; found: 907.4259 m/z.
Synthesis of Stearate-GRGDS:
GRGDS (25.2 mg, 51.4 μmol) and stearic acid N-hydroxysuccinimide ester (19.6 mg, 51.4
μmol) were suspended in a mixture of CH2Cl2, DMSO and H2O (1:1.4:1, 6.5 ml) and were
vigorously stirred at room temperature for 14 days. The solvent was carefully removed under
reduced pressure. The obtained residue was treated with MeOH/EtOAc (1:1, 3 ml) to give a
colorless precipitate that was collected by centrifugation. The obtained crude product was
washed with EtOAc/MeOH (9:1, 10 ml), EtOAc/CH2Cl2 (5:1, 8 ml) and EtOAc (6 ml).
Drying under reduced pressure provided stearate-GRGDS as a colorless solid (27.0 mg, 69%).
The MS spectra show additional signals [M-28] indicating that the product also contains the
corresponding palmitate GRGDS derivate.
61H NMR (500 MHz, DMSO-d6): δ = 10.00 (bs, 2H, COOH), 8.60–8.57, 8.18, 7.34, 7.10 (m, 
3 s, 3H, 2H, 1H, 3H, NH), 4.38–4.34 (m, 1H, NCHAsp), 4.27–4.23 (m, 1H, NCH(Arg)), 3.88
(dd, J = 11.8, 6.0 Hz, 1H, NCH(Ser)), 3.72, 3.71 (2 s, 2H each, CH2(Gly)), 3.58–3.51 (m, 2H,
CH2(Ser)), 3.19–3.10, 3.00–2.97 (2 m, 1H each, CH2(Arg)), 2.36–2.32, 2.62–2.55 (2 m, 1H each,
CH2(Asp)), 2.14–2.06 (m, 2H, CH2CH2CO), 1.97–1.86, 1.70–1.59, 1.57–1.49, (3 m, 2H, 1H,
1H, CH2(Arg)), 1.49–1.40 (m, 2H, CH2CH2CO), 1.23 (s, 28H, CH2), 0.85 (t, J = 6.8 Hz, 3H,
CH3) ppm. The signal for OH(Ser) could not unambiguously be assigned. 13C NMR (126 MHz,
DMSO-d6): δ = 174.8, 172.7, 172.5, 170.5, 169.3, 168.6, 164.3, (7 s, C=O), 157.3 (s, C=NH), 
62.3 (t, CH2(Ser)), 55.4 (d, CH(Ser)), 52.4 (d, CH(Arg)), 49.9 (d, CH(Asp)), 42.6, 42.0 (2 t,
CH2(Gly)), 40.6 (t, CH2(Arg)), 37.5* (t, CH2(Asp)), 35.2 (t, C-2), 32.1 (t, C-17), 31.3 (t, CH2(Arg)),
29.07, 29.02, 28.97, 28.9, 28.7 (5 t, CH2), 25.2 (t, C-3), 24.5 (t, CH2(Arg)), 22.1 (t, CH2), 14.0
(q, C-18) ppm. IR (ATR): ν = 3415–3070 (N―H, O―H), 2925, 2845 (C―H), 1640, 1530 
(C=O), 1460, 1385, 1235 cm-1. MS (MALDI): [M + H]+: C35H65N8O10+ calcd.: 757.48 m/z;
found: 757.00 m/z; [M' + H]+: C33H61N8O10+ calcd.:729.45 m/z; found: 729.53 m/z. MS (ESI-
TOF): [M + H]+: C35H65N8O10+ calcd.: 757.4818 m/z; found: 757.4814 m/z; [M + Na]+:
C35H64N8O10Na+ calcd.: 779.4638 m/z; found: 779.4630 m/z; [M' + H]+: C33H61N8O10+ calcd.:
729.4504 m/z; found: 729.4504; [M' + Na]+: C33H60N8O10Na+ calcd.: 751.4325 m/z; found:
751.4318 m/z.
Electrospinning:
PPDO (9% w/v in HFIP) solutions with two different concentrations of MeO-OEG7-GRGDS
or stearate-GRGDS were prepared by dissolving 0.18 g of PPDO in 2 ml of HFIP. Either 0.5
mg/ml or 1.4 mg/ml of the RGD constructs was added. The mixture was stirred for 3 h at
room temperature to achieve complete dissolution of the polymer and the respective RGD
construct. The solutions were electrospun in a custom built electrospinning setup (Supporting
Information Fig. S1). The solutions were dispensed through a 20G stainless steel needle
7(ID ~600 µm) (Precision Tips, Nordson EFD, Ohio, USA) from a 10 ml polypropylene
syringe mounted on a syringe pump (Cole-Palmer infusion pump EW-74900-05, Cole-
Parmer, London, UK) at a flow rate of 1 ml/h for all four solutions. The needle was connected
to a high-voltage DC power supply (HCP35-35000, FuG Elektronik, Rosenheim, Germany).
Aluminum foil was placed on top of the grounded collector that was used to collect the fibers.
The distance from the needle to the collector was 12 cm. The electrospinning was carried out
at room temperature and relative humidity of 25 ± 3 °C and 33 ± 8%, respectively.
PPDO patches co-electrospun with unmodified (free) RGD (Ac-Gly-Arg-Cys-Gly-Arg-Gly-
Asp-Ser-Pro-Gly-NH2) were prepared as previously reported.[6]
Electron microscopy:
The morphological properties of the samples were characterized using scanning electron
microscopy (SEM; Quanta 200 FEG ESEM instrument, FEI, Hillsborough, OR, USA).
Samples were sputtered with a gold coating (10 nm thickness) prior to SEM analysis. The
images obtained were then analyzed using the ImageJ software, and the fiber diameters (based
on > 50 measurements) were calculated. The jPOR plugin for ImageJ was additionally used to
determine the porosity of the samples. In order to improve the reliability of the calculation, at
least five SEM images were used to calculate the porosity for each sample.
X-ray photoelectron spectroscopy (XPS):
Surface composition was determined by XPS on a K-Alpha XPS (Thermo Scientific, East
Grinstead, UK). The X-ray source was a microfocused monochromatic Al-Kwith an energy
of 1486.6 eV. Typically, three positions per sample were analyzed, with a spot size of 400 
800 µm, and an emission angle of 0°.
8Biological Evaluation:
Human ADSCs were isolated from subcutaneous fat obtained from patients undergoing
liposuction at Saint-Louis Hospital, Paris, France with informed consent (Ethics committee
approval No.: 2010-07-10). Briefly, adipose tissue was washed in prewarmed sterile PBS,
after which the tissue was enzymatically dissociated through incubation for 45 min at 37 °C
with collagenase NB6 (SERVA Eletrophoresis). After digestion, filtration on 100 µm filters
and numeration, cells were resuspended in alphaMEM (Macopharma) supplemented with
10% fetal bovine serum (FBS) and 1% of antibiotic-antimycotic solution. Then, cells were
seeded at 10,000 cells/cm². Medium was changed twice a week, and at confluence cells were
dissociated with trypsin (Hyclone). hADSC phenotype was analyzed by flow cytometry. The
following monoclonal antibodies were used: CD29-FITC (Beckman Coulter), CD44-FITC
(BD Pharmingen), CD73-PE (BD Pharmingen), CD90-FITC (BD Pharmingen), CD105-PE
(R&D System), CD31-FITC (BD Pharmingen), CD34-FITC (Beckman Coulter) and CD45-
FITC (BD Pharmingen). Isotype control antibodies were included in all experiments: MsIgG1
isotype-FITC (BD Pharmingen) and MsIgG2b isotype-PE (Miltenyi biotec). Isolated hADSC
were seeded on 1 cm² patches, preliminary sterilized in 70% ethanol, at three densities for two
days. Cell viability on the seeded grafts was assessed by an MTT (3-[4, 5-dimethylthiazolyl-
2]-2, 5-diphenyltetrazolium bromide) assay. Briefly, 1 cm2 patches were seeded with 105, 106
or 3.5 ×106 hADSCs for 48 h. Subsequently 10 μl of 5 mg/ml MTT solution (Sigma-Aldrich) 
for 100 μl medium was added in each well. After 2 h of incubation at 37 °C, each sample was 
transferred in a 96-well plate and read with an ELISA plate reader (test wavelength of 570
nm, reference wavelength of 630 nm).
Results and Discussion
For this study, two chemically different moieties were selected to be attached to the peptide
GRGDS to serve as anchor groups for enhanced adhesion on a PPDO matrix, an OEG7 and a
9stearate. Stearate is more hydrophobic and may potentially allow stronger hydrophobic
interactions with the polymer matrix. OEG7 with its ether repetition unit is structurally more
similar to PPDO and may allow hydrophobic as well as dipole-dipole interactions resulting in
co-localization with the polymer during the electrospinning. The more hydrophilic peptide
part might then be displayed on the surface when an orientation of the RGD-linker constructs
during the electrospinning and evaporation occurs, which may be supported by the higher
steric demand of the peptide part. OEG7 and stearate are commercially available as NHS-
activated monofunctionalized species, and both have a similar molar mass—267 g · mol-1 for
the stearate moiety and 395 g · mol-1 for the OEG7—slightly lower than that of the RGD
peptide with 490 g · mol-1. For the targeted application, to promote a more efficient tissue
integration of polymer scaffolds, the anchor moieties should feature sufficient size (molecular
weight) to allow efficient physical interactions with the polymer matrix while being small
enough with respect to the size of the RGD-peptide. In this way, its biointeractions and
therefore biological activity are not reduced.
Attachment of GRGDS to the anchor groups was realized by reaction of the N-terminus of
GRGDS with the N-hydroxysuccinimidylated linkers in solution at room temperature (Figure
1). In case of the stearate linker, a biphasic solvent mixture and vigorous stirring were
employed, as no solvent capable of dissolving both the hydrophobic stearate NHS ester and
the hydrophilic peptide could be identified. The reaction process was followed by
consumption of the peptide via ninhydrin staining on silica TLC plates.
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Figure 1. (a) Coupling of GRGDS to OEG7-NHS ester; (b) coupling of GRDGS to stearic
acid NHS ester.
While the stearate adduct could be isolated by precipitation in 69% yield, the OEG7 adduct
required HPLC purification, resulting in a slightly lower yield (51%). The products were
characterized by 1H- and 13C NMR as well as FT-IR spectroscopy and mass spectrometry. In
the NMR and IR spectra (see Supporting Information Figs S2 and S3), signals of both
components were found, and integration of the 1H-NMR signals showed the correct ratio of
the two components (1:1 coupling) and no presence of unreacted starting materials. However,
more detailed analysis by MALDI-ToF (Figure 2) and ESI mass spectrometry revealed that in
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both cases the linker starting materials were not pure, but contained structurally related
derivatives. This contamination led into formation of corresponding GRGDS by-products in
the coupling step that were not efficiently removed by the employed purification methods.
Figure 2. Excerpts of the MALDI ToF spectra of OEG7-GRGDS (top) and stearate-GRGDS
(bottom) showing expected signals for the desired coupling products and in addition signals
for structurally related by-products.
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In the case of the OEG anchor group, not only the OEG7 species, but also OEG6, OEG8, and,
to a minor extent, also OEG of other lengths were present in the samples and could not be
completely separated from OEG7 by HPLC. Given the synthetic routes used, such impurities
are generally anticipated in oligomers; interestingly, the stearate also contained impurities of a
similar compound, in this case the corresponding palmitate. While in view of the planned use
in the co-electrospinning, the identified impurities did not interfere, it is important to note that
a detailed analysis of compounds is recommended in such syntheses, as without the mass
spectrometry the presence of mixtures would not have been disclosed.
In a next step, mixtures of the RGD linker constructs in two different ratios (1.4 or 0.5 mg/ml,
corresponding to 1.5 or 0.5 wt% content) and PPDO were co-electrospun (electrospinning
setup: see Supporting Information Fig. S1). Figure 3 depicts electron microscopy pictures of
the electrospun non-woven mats. In all cases, the co-electrospinning proceeded well, and the
fiber orientation, fiber diameter, and porosity (see Table 1) were comparable for all
investigated samples and are very similar to pure electrospun PPDO.[6]
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Figure 3. Electron microscopy pictures of fibers co-electrospun from solutions of PPDO with
OEG7-GRDGS (top) or stearate-GRGDS (bottom). The concentration of RGD-linker
constructs did not significantly influence the fiber diameters.
Table 1. Fiber diameters and porosities of the co-electrospun PPDO patches.
Co-electrospinning
additive
Fiber diameter
± standard deviation [nm]
Porosity
± standard deviation [%]
OEG7-GRGDS 0.5 mg/ml 894 ± 57 47 ± 1
OEG7-GRGDS 1.4 mg/ml 832 ± 44 48 ± 0.5
Stearate-GRGDS 0.5 mg/ml 803 ± 44 45 ± 0.5
Stearate-GRGDS 1.4 mg/ml 903 ± 48 44 ± 0.2
It was expected that by increasing the amount of GRGDS linker constructs in solution, the
peptide content in the fibers would also increase. This was investigated by FT-IR and XPS.
The FT-IR spectra (Supporting Information Fig. S4) showed only absorptions indicative of
14
PPDO, while the peptide could not be detected. This is likely to be related to the low content
of peptide in the overall matrix (≤2 wt%). 
In the XPS, the presence of the peptide on the surface could be demonstrated by the
occurrence of a nitrogen signal, which was not present in the pure PPDO sample (Table 2). It
should be noted that for a homogeneous distribution of the peptide in the matrix, the expected
nitrogen content would be lower (0.2–0.5 at%) than found (0.5–1.4 at%). This suggests a
preferential presentation of the peptide on the surface of the fibers rather than its embedding
into the PPDO matrix.
Table 2. Surface composition of PPDO co-electrospun with RGD-linker constructs in
different compositions and pure PPDO, determined by XPS.
RGD type and conc.
(mg/ml)
Surface
C (at.%)
Surface
N (at.%)
Surface
O (at.%)
OEG7 0.5 mg/ml 66.2 ± 1.5 0.9 ± 0.1 33.0 ± 1.4
OEG7 1.4 mg/ml 64.0 ± 1.9 0.5 ± 0.1 35.5 ± 2.0
Stearate 0.5 mg/ml 65.7 ± 0.8 1.4 ± 0.1 33.0 ± 0.9
Stearate 1.4 mg/ml 67.9 ± 0.7 0.7 ± 0.2 31.4 ± 0.7
PPDO 58.1 ± 0.4 0.0 38.7 ± 0.2
The stearate compound was associated with a somewhat higher nitrogen presence on the
surface, which may indicate an orientation of the RGD-linker-construct with the more
hydrophobic part being embedded in the polymer matrix, while the peptide part is on the
surface. In case of the OEG linker, this orientation is presumably less pronounced.
Interestingly, the nitrogen content did not increase with the concentration of the linker
construct. What should be furthermore considered is the rather limited surface area, which can
be analyzed by XPS, so it is also conceivable that the peptide is not homogeneously
distributed on the surface, but that microphase separation phenomena in the solution used for
electrospinning have resulted in an inhomogeneous display of the peptide. In a previous study,
co-electrospun PPDO/RGD-peptide without physical anchor groups[6] showed slightly higher
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nitrogen content (peptide concentration) at the fiber surface measured by XPS. This may
indicate a higher embedding extent of the RGD-linker constructs into the PPDO matrix than
in the case of non-functionalized RGD. This could potentially translate into a prolonged
presentation of the biologically active peptide on the polymer matrix surface over time during
the course of hydrolytic degradation of the polymer matrix in vivo.
In a preliminary biological evaluation, hADSC were cultured on the patches containing
OEG7-GRGDS, and cell viability was determined by a MTT assay. This colorimetric test
measures the chemical reduction of MTT into formazan, which is directly proportional to the
number of viable cells. The results were compared to hADSC cultured on PPDO co-
electrospun with a pristine RGD peptide (Figure 4). While the number of viable cells
expectedly increased with increased initial cell densities, viability was actually not
significantly different for the different types of RGD peptide (pristine or linker-bound) and
was comparable to pure electrospun PPDO.[6]
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Figure 4. Viability of human adipose-derived stem cells (MTT-test) cultured on electrospun
patches of PPDO containing non-functionalized RGD peptide and RGD linker construct in
different concentrations; co-electrospinning additives from left to right: non-functionalized
RGD (0.5 () and 1.4 () mg/ml) and OEG7-GRGDS (0.5()/1.4 () mg/ml).
Conclusion
RGD constructs with physical anchor groups were successfully synthesized and could be co-
electrospun with PPDO into nanofibers, putatively with hydrophobic interactions stabilizing
the construct within the core of the matrix while the hydrophilic peptide is preferentially
presented on the surface. Incorporation of RGD did not affect the fiber morphology of the
electrospun scaffolds. RGD could be detected on the surface by XPS, but not by IR. The
increase in RGD in the feeding solution did not lead to increased RGD display, suggesting
that either the RGD is partially embedded into the fibers and/or that its distribution is
inhomogeneous. In any case, the fully characterized RGD-linker constructs add to the toolbox
of biomaterial scientists for the further development of tissue integrating polymers as they
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offer the possibility for an enhanced adhesion of the biological active moiety (RGD-peptide)
through physical interactions at the interface between the polymer matrix and living tissue.
While the present report is focused on the synthesis of the RGD linker-constructs and its
utilization for co-electrospinning, additional studies to compare the tissue integration of co-
electrospun PPDO/RGD-linker constructs to that of PPDO/non-functionalized RGD scaffolds
are required to fully explore the potential of the presented linker constructs in vivo.
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